Orogen Royalties Announces Equity Compensation for 2025

Orogen Royalties Inc. has announced its annual share-based compensation for 2025, as approved by the Board of Directors. The grants include 324,000 Restricted Share Units (RSUs), 62,000 Deferred Share Units (DSUs), and 977,000 incentive Stock Options. These are allocated to directors, officers, employees, and consultants under the Omnibus Equity Incentive Compensation Plan ratified in October 2024. The RSUs are set to fully vest two years after the grant date, while the DSUs will vest in two equal installments on the third and fourth anniversaries.

Stock Options have a five-year lifespan with a $1.51 exercise price, vesting over three years. A quarter of the options will vest immediately, followed by another 25% annually on the first, second, and third anniversaries. Regulatory acceptance from the TSX Venture Exchange remains pending.